Speak directly to the analyst to clarify any post sales queries you may have.
The global blood processing devices and consumables market is experiencing significant evolution, propelled by technology integration, regulatory shifts, and increasing demand for safe, effective transfusion solutions within healthcare systems worldwide.
Market Snapshot: Blood Processing Devices & Consumables
The Blood Processing Devices & Consumables Market grew from USD 51.02 billion in 2024 to USD 56.64 billion in 2025. With a robust CAGR of 10.88%, the market is projected to reach USD 116.60 billion by 2032. As healthcare organizations prioritize advanced blood management and automation, this segment has emerged as a critical pillar of clinical best practice and patient safety across hospitals, diagnostic laboratories, and research settings.
Scope & Segmentation of the Global Market
This comprehensive market research report details a multi-dimensional analysis and forecast of the blood processing devices and consumables industry across multiple axes:
- Product Types: Consumables such as anticoagulants and additives, blood bags and sets, filters, and test kits; Devices including apheresis machines, centrifuges, pathogen reduction systems, and storage equipment.
- Technology: Automated processing platforms, encompassing both fully automated and semi-automated systems; Manual processing workflows supporting specialized operations.
- Application Areas: Blood collection, component separation, diagnostic testing, pathogen reduction, and storage and transportation.
- End Users: Blood banks, diagnostic laboratories, hospitals and clinics, and research institutes addressing both routine and specialized transfusion requirements.
- Distribution Channels: Direct sales models, distributors, and e-commerce platforms that support rapid procurement and market reach.
- Regional Coverage: Americas (North America and Latin America), Europe, Middle East & Africa, and Asia-Pacific, including key national markets and emerging economies.
- Company Landscape: In-depth analysis of leading market participants, including multinational manufacturers and specialized suppliers driving innovation and strategic collaborations in blood processing.
Key Takeaways for Senior Decision-Makers
- Technology-driven automation is replacing manual blood processing, delivering greater consistency of outcomes while reducing reliance on operator skill.
- Pathogen reduction solutions are gaining momentum, prompted by concerns over disease transmission and the need for robust regulatory compliance in transfusion safety.
- Collaborative product development and R&D partnerships are accelerating innovation in both device functionality and consumable formulations.
- Digital connectivity is enabling real-time data monitoring, supporting predictive device maintenance and enhancing supply chain transparency for consumables.
- Strategic expansion into emerging markets requires scalable, modular systems and adaptive supply models, given diverse infrastructure and regulatory environments.
- Leaders are prioritizing manufacturing agility and establishing regional production hubs to secure supply continuity in dynamic global conditions.
Assessing Tariff Impact and Supply Chain Dynamics
The introduction of new United States trade tariffs in 2025 will affect procurement costs and supply chain continuity for both devices and consumables. This shift compels manufacturers to explore near-shoring, diversify suppliers, and qualify domestic vendors. Proactive engagement with regulatory authorities and industry consortia can support tariff mitigation and expedite the flow of critical blood safety products.
Methodology & Data Sources
This market analysis employs a multi-phase methodology, blending secondary research across scientific literature, regulatory filings, and industry reports, with primary interviews involving industry leaders. Data triangulation and expert validation ensure the integrity and relevance of findings, delivering actionable perspectives for strategic planning.
Why This Report Matters
- Supports investment and procurement decisions with detailed segmentation, technology trends, and regional dynamics tailored for executive stakeholders.
- Equips organizations with clarity on risk-mitigation strategies in the face of shifting trade policy and regulatory frameworks.
- Reveals innovation drivers shaping next-generation blood component separation, testing, and safety systems in global healthcare environments.
Conclusion
The blood processing devices and consumables sector is entering a phase of accelerated change, guided by advanced technology adoption, regulatory alignment, and agile supply strategies. Stakeholders leveraging data-driven insights and ongoing collaboration are positioned to achieve operational resilience and drive clinical value.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this Blood Processing Devices & Consumables market report include:- Haemonetics Corporation
- Terumo Corporation
- Pall Corporation
- Fresenius Kabi AG
- Grifols, S.A.
- Octapharma AG
- Macopharma S.A.
- GE Healthcare Technologies Inc.
- Bio-Rad Laboratories, Inc.
- Miltenyi Biotec GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 181 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 56.64 Billion |
| Forecasted Market Value ( USD | $ 116.6 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
